April 2020 Anthem Maine Provider News

Contents

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Information from Anthem for Care Providers about COVID-19

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Anthem acquires Beacon Health Options

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Provider Manual to be updated July 1, 2020

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Continued focus on updates to public provider website

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

MCG Care Guidelines 24th Edition

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Provider transparency update

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

HEDIS 2020 Federal Employee Program® medical records request requirements

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Anthem to delay most April 1 formulary list updates for commercial health plan pharmacy benefit

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Specialty pharmacy updates effective July 1, 2020

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Pharmacy information available on anthem.com

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

2020 Medicare risk adjustment provider trainings

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Medical drug benefit clinical criteria updates - November 2019

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Medical drug benefit clinical criteria updates - December 2019

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Keep up with Medicare news

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Anthem acquires Beacon Health Options

Anthem completed its acquisition of Beacon Health Options, a large behavioral health organization that serves more than 36 million people across the country. The company will operate as a wholly owned subsidiary of Anthem.

 

Bringing together our existing solid behavioral health business with Beacon’s successful model and support services creates one of the most comprehensive behavioral health networks in the country. It’s also an opportunity to offer best-in-class behavioral health capabilities and whole person care solutions in new and meaningful ways to help people live their best lives.

 

From the standpoint of our customers and providers at this time, it’s business as usual:

 

  • Members should continue to call the customer service number on the back of their membership card or access their health plan’s website for online self-service.
  • Providers should continue to use the provider service contact information, websites and online self-service portals as part of their agreement with either Anthem or Beacon.
  • There will be no immediate changes to the way Anthem or Beacon manage their respective provider networks, contracts and fee arrangements. Anthem and Beacon provider networks, contracts and fee arrangements will remain separate at this time.

 

We know our providers continue to expect more of their healthcare partner, and at Anthem, we aim to deliver more in return.

 

For more details, please see the press release.

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Provider Manual to be updated July 1, 2020

The Provider Manual will be updated for an effective date of July 1, 2020, and will be available after May 1 on the provider portal of our website, anthem.com. Select Providers, then, under the Provider Resources heading, select Policies, Guidelines and Manuals. Enter Maine as state, scroll to Provider Manuals and select Download the Manual. Archived copies of the 2018 and 2019 provider manual will remain available at the same location for reference to prior information. However, for current reference needs, please ensure that you select the July 2020 manual after July 1, 2020.

 

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Continued focus on updates to public provider website

We continue to make changes to our public provider website to make it easier for you to find the information you need. The end of Q1 brings a few updates for the site at anthem.com:

 

  • Information has been added to our website regarding Patient Centered Specialty Care (PCSC) – our value-based payment program for cardiology, endocrinology and obstetrics/gynecology providers. You can find this information online as an extension of our Enhanced Personal Health Care (EPHC) program – our broad patient-centered, value-based care program.
  • Documents listed on the Prior Authorization page can be conveniently accessed via online links.
  • Medicare Advantage will be live in the coming days. You will be able to view updated Medicare Advantage pages on the commercial public sites.
  • Medical Policies and Clinical Utilization Management Guidelines now display on our newly designed web pages.

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

MCG Care Guidelines 24th Edition

Effective July 1, 2020, we will upgrade to the 24th edition of MCG care guidelines for the following modules: Inpatient & Surgical Care (ISC), General Recovery Care (GRC), Chronic Care (CC), Recovery Facility Care (RFC), and Behavioral Health Care (BHC). The below tables highlight new guidelines and changes that may be considered more restrictive.

 

Goal Length of Stay (GLOS) Changes for Inpatient & Surgical Care (ISC) and Behavioral Health Care (BHC)

Guideline

MCG Code

24th Edition GLOS

23rd Edition GLOS

Aortic Valve Replacement, Transcatheter

S-1320 

2 days postoperative

3 days postoperative

Appendectomy, with Abscess or Peritonitis, by Laparoscopy

S-185

Ambulatory or 2 days postoperative

2 days postoperative 

Appendectomy, without Abscess or Peritonitis, by Laparoscopy

S-175

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Repair of Pelvic Organ Prolapse

S-1020

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Urethral Suspension Procedures

S-850

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Appendectomy, with Abscess or Peritonitis, by Laparoscopy, Pediatric

P-30

Ambulatory or 2 days postoperative

2 or 3 days postoperative 

Appendectomy, without Abscess or Peritonitis, by Laparoscopy, Pediatric

P-20

Ambulatory postoperative

Ambulatory or 1 day postoperative 

Tibial Osteotomy, Child or Adolescent

S-1131

Ambulatory or 1 day postoperative

1 day postoperative 

Schizophrenia Spectrum Disorders, Adult: Inpatient Care

B-014-IP

5 days

6 days

Schizophrenia Spectrum Disorders, Child or Adolescent: Inpatient Care

B-027-IP

5 days

6 days

Transcranial Magnetic Stimulation

B-801-T

Utilize B-801-T for Clinical Indications for procedure

Refer to BEH.00002 for Clinical Indications for procedure

 

New Optimal Recovery Guidelines (ORGs) for Inpatient & Surgical Care (ISC) and New Behavioral Health Care (BHC) New Guidelines

 

Body System

Guideline Title

MCG Code

Pediatrics

Appendectomy, with Abscess or Peritonitis, Pediatric

P-35

Pediatrics

Appendectomy, without Abscess or Peritonitis, Pediatric

P-25

Home Care Behavioral Health

Attention-Deficit and Disruptive Behavior Disorders

B-003-HC

Home Care Behavioral Health

Autism Spectrum Disorders

B-012-HC

 

Anthem Customizations to MCG care guideline 24th Edition

Effective July 1, 2020, the following MCG care guideline 24th edition customizations will be implemented.

 

  • Carotid Artery Stenting (W0165) – Clinical Indications were customized to reference CG-SURG-76 Carotid, Vertebral and Intracranial Artery Stent Placement with or without Angioplasty
  • Deep Brain Stimulation (W0164) – Clinical Indications were customized to refer to SURG.00026 Deep Brain, Cortical, and Cerebellar Stimulation.
  • Vagus Nerve Stimulation, Implantable (W0166) – Clinical Indications were customized to refer to SURG.00007 Vagus Nerve Stimulation.


To view a detailed summary of customizations, scroll down to other criteria section and select Customizations to MCG Care Guidelines 24th Edition.

 

For questions, please contact the provider service number on the back of the member's ID card.

 

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Provider transparency update

A key goal of Anthem’s provider transparency initiatives is to improve quality while managing health care costs. One of the ways is through Anthem’s value-based programs such as Enhanced Personal Health Care, Bundled Payment Programs, Oncology Medical Home, and so on – called the “Programs.”  Certain providers (“Value-Based Program Providers” also known as “Payment Innovation Providers”) in Anthem’s various value-based programs receive quality, utilization and/or cost data, reports, and information about the health care providers (“Referral Providers”) to whom the Value-Based Program Providers may refer their patients covered under the Programs. If a Referral Provider is higher quality and/or lower cost, this component of the Programs should result in the provider getting more referrals from Value-Based Program Providers. The converse should be true if Referral Providers are lower quality and/or higher cost.

 

Providing this type of data, including comparative cost information, to Value Based Program Providers helps them make more informed decisions about managing health care costs and maintaining and improving quality of care. It also helps them succeed under the terms of the Programs.

 

Additionally, employers and group health plans (or their representatives or vendors) may also be given quality/cost/utilization information about Value Based Program Providers and Referral Providers so that they can better understand how their health care dollars are being spent and how their health benefits plans are being administered. This will, among other things, give them the opportunity to educate their employees and plan members about the benefits of using higher quality and/or lower cost health care providers.

 

Anthem will share data on which it relied in making these quality/cost/utilization evaluations upon request, and will discuss it with Referral Providers - including any opportunities for improvement. For questions or support, please refer to your local Market Representative or Care Consultant.

AdministrativeAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

HEDIS 2020 Federal Employee Program® medical records request requirements

Centauri Health Solutions is the contracted vendor to gather member medical records on behalf of the Blue Cross and Blue Shield Federal Employee Program. We value the relationship with our providers, and ask that you respond to the detailed requests in support of risk adjustment, HEDIS and other government-required activities within the requested timeframe. Centauri Health will work with you to obtain records via fax, mail, remote electronic medical record (EMR) access, or onsite scanning/EMR download (as necessary).

 

We ask that you please promptly comply within five (5) business days of the record requests. If you have any questions, please contact Ify Ifezulike with Blue Cross and Blue Shield Federal Employee Program at 202-626-4839 or Mary Kay Sander with Centauri at 636-333-9145.

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Anthem to delay most April 1 formulary list updates for commercial health plan pharmacy benefit

In light of the current situation with COVID-19, we have decided to delay the implementation of many of the previously communicated formulary changes scheduled for April 1, 2020.

 

The changes listed below will still go into effect on April 1, 2020:

 

 

National/Preferred Drug List

Traditional Open

Drug List

Essential

Drug List

Antihistamines

 

 

 

carbinoxamine 6mg

Tier 1 -> NF

Tier 1 -> Tier 3

Tier 1 -> NF

Topical Anesthetics

 

 

 

Lidocaine 7%-Tetracaine 7% cream

Tier 3/NF -> NF

Tier 3 (No Change)

NF (No Change)

Pliaglis cream

Tier 3/NF -> NF

Tier 3 (No Change)

NF (No Change)

 

Please note, this update does not apply to the Select Drug List and does not impact Medicaid and Medicare plans.

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Specialty pharmacy updates effective July 1, 2020

Prior authorization

Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our prior authorization review process.

 

Please note: inclusion of NDC code on claims will help expedite claim processing of drugs billed with a not otherwise classified (NOC) code.

 

To access the clinical criteria document information please click here.  

 

Pre-service clinical review of non-oncology specialty pharmacy drugs will be managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology indications will be managed by AIM Specialty Health® (AIM), a separate company, and are in italics in the grid below.

 

Clinical Criteria

HCPCS or CPT Code(s)

Drug

*ING-CC-0003

C9399, J3490, J3590

Xembify

ING-CC-0062

J3590

Eticovo

ING-CC-0062

J3490

Hadlima

ING-CC-0072

J0179

Bevou

ING-CC-0152

J3490

Vyondys 53

ING-CC-0153

C9399, J3490, J3590

Adakveo

ING-CC-0154

C9399, J3490, J3590

Givlaari

* Non-oncology use is managed by Anthem’s medical specialty drug review team; oncology use is managed by AIM.

 

Step therapy updates

Effective for dates of service on and after July 1, 2020, the following specialty pharmacy codes from new or current clinical criteria will be included in our existing specialty pharmacy medical step therapy review process.

 

Orencia will be the non-preferred agent for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriatic arthritis. The table below will assist you in identifying the applicable preferred agents and clinical criteria.

 

To access the clinical criteria document information please click here.

 

Rheumatoid Arthritis (RA)

Clinical Criteria

HCPCS or CPT Code

Preferred Agents

Clinical Criteria

HCPCS or CPT Code

Non-Preferred Agent

ING-CC-0062

J1438

Enbrel

ING-CC-0078

J0129

Orencia

ING-CC-0062

J0135

Humira

ING-CC-0078

J0129

Orencia

ING-CC-0062

J3590

Simponi

ING-CC-0078

J0129

Orencia

ING-CC-0062

J1602

Simponi Aria

ING-CC-0078

J0129

Orencia

ING-CC-0062

J1745

Remicade

ING-CC-0078

J0129

Orencia

 

Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Clinical Criteria

HCPCS or CPT Code

Preferred Agents

Clinical Criteria

HCPCS or CPT Code

Non-Preferred Agent

ING-CC-0062

J1438

Enbrel

ING-CC-0078

J0129

Orencia

ING-CC-0062

J0135

Humira

ING-CC-0078

J0129

Orencia

 

Psoriatic Arthritis (PsA)

Clinical Criteria

HCPCS or CPT Code

Preferred Agents

Clinical Criteria

HCPCS or CPT Code

Non-Preferred Agent

ING-CC-0042

C9399

J3490

J3590

Cosentyx

ING-CC-0078

J0129

Orencia

ING-CC-0062

J1438

Enbrel

ING-CC-0078

J0129

Orencia

ING-CC-0062

J0135

Humira

ING-CC-0078

J0129

Orencia

ING-CC-0062

J3590

Simponi

ING-CC-0078

J0129

Orencia

ING-CC-0062

J1602

Simponi Aria

ING-CC-0078

J0129

Orencia

ING-CC-0062

J1745

Remicade

ING-CC-0078

J0129

Orencia

ING-CC-0063

J3357

Stelara

ING-CC-0078

J0129

Orencia

PharmacyAnthem Blue Cross and Blue Shield | CommercialMarch 31, 2020

Pharmacy information available on anthem.com

For more information on copayment/coinsurance requirements and their applicable drug classes, drug lists and changes, prior authorization criteria, procedures for generic substitution, therapeutic interchange, step therapy or other management methods subject to prescribing decisions and other requirements, restrictions or limitations that apply to certain drugs, visit anthem.com/pharmacyinformation. The commercial and marketplace drug lists are reviewed and updates are posted to the website quarterly (the first of the month for January, April, July and October).

  • To locate the commercial drug list, select ‘Click here to access your drug list’.
  • To locate the Marketplace Select Formulary and pharmacy information, scroll down to ‘Select Drug Lists’, then select the applicable state’s drug list link.


Federal Employee Program (FEP) pharmacy updates and other pharmacy related information may be accessed at www.fepblue.org > Pharmacy Benefits. This drug list is also reviewed and updated regularly as needed.

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

2020 Medicare risk adjustment provider trainings

The Medicare Risk Adjustment Regulatory Compliance team at Anthem Blue Cross and Blue Shield offers two provider training programs regarding Medicare risk adjustment and documentation guidelines. Information for each training is outlined below.

 

Medicare Risk Adjustment and Documentation Guidance (General)

  • When: The trainings will be offered the first Wednesday of each month from 1:00 p.m. to 2:00 p.m. (through December 2, 2020).
  • Learning objective: This onboarding training will provide an overview of Medicare risk adjustment, including the Risk Adjustment Factor and the Hierarchical Condition Category (HCC) model, with guidance on medical record documentation and coding.
  • Credits: This live activity has been reviewed and is acceptable for up to 1 prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

For those interested in joining us to learn how providers play a critical role in facilitating the risk adjustment process, register for one of the monthly training sessions at the following link: Medicare Risk Adjustment and Documentation Guidance (General).

 

Note: Dates may be modified due to holiday scheduling.

 

Medicare Risk Adjustment, Documentation and Coding Guidance (Condition Specific)

  • When: The trainings will be offered on the third Wednesday of every other month from noon to 1 p.m. ET (from January 15, 2020, to November 18, 2020).
  • Learning objective: This training series will provide in-depth disease information pertaining to specific conditions including an overview of their corresponding HCC, with guidance on documentation and coding.
  • Credits: This live series activity has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity

 

For those interested in joining us for this six-part training series, please see the list of topics and scheduled training dates below:

 

  1. Red Flag HCCs Part 1 (January 15, 2020): Register for a recording of the session: Training will cover HCCs most commonly reported in error as identified by CMS (Chronic Kidney Disease Stage 5, Ischemic or Unspecified Stroke, Cerebral Hemorrhage, Aspiration and Specified Bacterial Pneumonias, Unstable Angina and Other Acute Ischemic Heart Disease, End-Stage Liver Disease).

Link: Red Flag Hierarchical Condition Categories (HCCs), part one

 

  1. Red Flag HCCs Part 2 (March 18, 2020): Training will cover HCCs most commonly reported in error as identified by CMS (Atherosclerosis of the Extremities with Ulceration or Gangrene, Myasthenia Gravis/Myoneural Disorders and Guillain-Barre Syndrome, Drug/Alcohol Psychosis, Lung and Other Severe Cancers, Diabetes with Ophthalmologic or Unspecified Manifestation)

Link: Medicare Risk Adjustment Documentation and Coding Guidance: Red Flag HCC's Part 2

 

  1. Neoplasms (May 20, 2020)

Link: Neoplasms

 

  1. Acute, Chronic and Status Conditions (July 15, 2020)

Link: Acute, Chronic and Status Conditions

 

  1. Diabetes Mellitus and Other Metabolic Disorders (September 16, 2020)

Link: Diabetes Mellitus and Other Metabolic Disorders

 

  1. TBD — This Medicare risk adjustment webinar will cover the critical topics and updates that surface during the year (November 18, 2020):

Link: Topic TBD

 

ABSCRNU-0125-20

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Medical drug benefit clinical criteria updates - November 2019

On November 15, 2019, the Pharmacy and Therapeutics (P&T) Committee approved clinical criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield (Anthem) and AMH Health, LLC (AMH Health). These policies were developed, revised or reviewed to support clinical coding edits.

 

The clinical criteria is publicly available on the provider websites, and the effective dates will be reflected in the Clinical Criteria Web Posting November 2019 (Anthem) and Clinical Criteria Web Posting November 2019 (AMH Health). Visit Clinical Criteria to search for specific policies.

 

For questions or additional information, use this email.

 

ABSCRNU-0124-20

AMHCRNU-0007-20

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Medical drug benefit clinical criteria updates - December 2019

On December 18, 2019, and December 23, 2019, the Pharmacy and Therapeutics (P&T) Committee approved clinical criteria applicable to the medical drug benefit for Anthem Blue Cross and Blue Shield (Anthem) and AMH Health, LLC (AMH Health). These policies were developed, revised or reviewed to support clinical coding edits.

 

The clinical criteria is publicly available on the provider websites, and the effective dates will be reflected in the Clinical Criteria Web Posting December 2019 (Anthem) and the Clinical Criteria Web Posting December 2019 (AMH Health). Visit Clinical Criteria to search for specific policies.

 

For questions or additional information, use this email.

 

ABSCRNU-0130-20

AMHCRNU-0009-20

State & FederalAnthem Blue Cross and Blue Shield | Medicare AdvantageMarch 31, 2020

Keep up with Medicare news